| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.5658 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6124 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6231 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6330 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6443 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6610 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6900 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.6999 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7107 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7113 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7256 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7313 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7338 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7387 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7484 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7529 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7570 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7572 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7593 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7654 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7832 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7889 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7919 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7927 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.7934 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8020 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8132 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8388 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8456 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8553 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8611 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8630 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8658 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8672 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8676 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8701 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8740 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8775 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8782 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8803 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8804 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8822 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8829 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8835 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8934 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.8943 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9037 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9046 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9071 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9079 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9155 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9157 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9159 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9178 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9225 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9243 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9254 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9265 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9267 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9348 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9356 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9399 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9400 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9402 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9405 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9423 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9522 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9551 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9563 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9575 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9586 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9628 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9634 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9701 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9756 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9766 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9830 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9845 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9865 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9868 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9883 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9889 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9898 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9941 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9949 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9969 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9981 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9986 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9986 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9991 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9996 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 0.9997 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0000 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0000 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0000 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0013 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0013 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0018 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0039 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0092 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0093 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0094 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0121 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0168 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0218 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0226 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0236 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0266 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0266 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0270 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0318 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0323 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0331 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0383 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0393 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0424 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0436 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0460 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0461 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0532 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0538 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0543 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0615 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0629 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0638 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0653 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0690 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0717 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0732 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0751 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0812 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0894 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.0967 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1016 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1042 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1042 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1061 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1061 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1068 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1069 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1077 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1107 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1120 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1158 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1166 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1174 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1180 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1216 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1244 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1375 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1395 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1400 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1420 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1425 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1436 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1469 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1509 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1522 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1545 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1556 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1633 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1634 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1638 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1663 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1677 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1703 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1704 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1770 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1788 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1866 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.1943 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2032 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2059 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2059 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2104 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2144 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2246 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2364 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.2769 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.3018 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.3432 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.4768 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.5585 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.5651 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.6293 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.6790 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | phenylalanine | 1.9175 | scaled units | Placebo | BASELINE |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|